Low-dose immunoglobulin G is not associated with mortality in patients with sepsis and septic shock

Yusuke Iizuka; Naoto Hori; Masahiro Yamane; Daisuke Kudo; Yuya Kitai; Shodai Yoshihiro; Akihito Tampo; Takeo Azuhata; Hiroki Takahashi; Masayuki Watanabe; Sho Nachi; Motohiro Sekino; Kazuhiro Shiga; Keiko Ueno; Shuhei Takauji; Kohei Takimoto; Mineji Hayakawa; Yoshihiko Nakamura; Nobuyuki Saito; Yoshiaki Iwashita; Yusuke Sasabuchi; Hiroshi Takahashi; Toshihiko Mayumi; Yuko Okuda; Kensuke Umakoshi; Takayuki Ogura; Toru Miike; Masamitsu Sanui; Takafumi Todaka; Kazuma Yamakawa; Takehiko Kasai; Wataru Matsunaga; Yutaka Kondo; Fumihito Ito; Eiichiro Noda; Tsuyoshi Nakashima; Masato Murata; Hideaki Arai; Iwao Kobayashi; Kohkichi Andoh; Shigehiko Uchino; Hiroshi Kodaira; Yoshiaki Yoshikawa; Sekine Ryosuke; Katsura Hayakawa; Shinjiro Saito; Alan Kawarai Lefor

doi:10.1186/s13054-017-1764-4

Low-dose immunoglobulin G is not associated with mortality in patients with sepsis and septic shock

Yusuke Iizuka(RIKEN Center for Integrative Medical Sciences), Naoto Hori(Tottori University Hospital), Masahiro Yamane(Tokyo Medical and Dental University), Daisuke Kudo(Barrow Neurological Institute), Yuya Kitai(Nerima General Hospital), Shodai Yoshihiro(Hiroshima University Hospital), Akihito Tampo(Asahikawa Medical University), Takeo Azuhata, Hiroki Takahashi(Azabu University), Masayuki Watanabe(Fukushima Medical University), Sho Nachi(Apple (Israel)), Motohiro Sekino(Nagasaki University Hospital), Kazuhiro Shiga(Apple (Israel)), Keiko Ueno(Apple (Israel)), Shuhei Takauji, Kohei Takimoto(Apple (Israel)), Mineji Hayakawa(Hokkaido University Hospital), Yoshihiko Nakamura(Harvard University), Nobuyuki Saito(Chiba Hokusou Hospital), Yoshiaki Iwashita(Shimane University), Yusuke Sasabuchi(Diagnostics for the Real World (United States)), Hiroshi Takahashi(General Hospital of Drama), Toshihiko Mayumi(Nagoya University), Yuko Okuda(Apple (Israel)), Kensuke Umakoshi(Apple (Israel)), Takayuki Ogura(Saiseikai Utsunomiya hospital), Toru Miike(Apple (Israel)), Masamitsu Sanui(Jichi Medical University), Takafumi Todaka(Apple (Israel)), Kazuma Yamakawa(Fundación Juan March), Takehiko Kasai(Apple (Israel)), Wataru Matsunaga(Kobe International University), Yutaka Kondo(Juntendo University Urayasu Hospital), Fumihito Ito(Apple (Israel)), Eiichiro Noda(Apple (Israel)), Tsuyoshi Nakashima(Apple (Israel)), Masato Murata(Apple (Israel)), Hideaki Arai(Gladstone Institutes), Iwao Kobayashi(Apple (Israel)), Kohkichi Andoh(Apple (Israel)), Shigehiko Uchino(The Jikei University Hospital), Hiroshi Kodaira(Apple (Israel)), Yoshiaki Yoshikawa(Apple (Israel)), Sekine Ryosuke(Apple (Israel)), Katsura Hayakawa(Saitama Red Cross Hospital), Shinjiro Saito(Jikei University School of Medicine), Alan Kawarai Lefor(Jichi Medical University)

Critical Care

July 11, 2017

10.1186/s13054-017-1764-4

Cited by 31

Related Papers

Diagnostic criteria and severity assessment of acute cholecystitis: Tokyo Guidelines

|Journal of Hepato-Biliary-Pancreatic Surgery|2007|584

36th International Symposium on Intensive Care and Emergency Medicine

|Critical Care|2016|526

Definitions, pathophysiology, and epidemiology of acute cholangitis and cholecystitis: Tokyo Guidelines

|Journal of Hepato-Biliary-Pancreatic Surgery|2007|489

Antiamyloidogenic and Neuroprotective Functions of Cathepsin B: Implications for Alzheimer's Disease

|Neuron|2006|466

Diagnostic criteria and severity assessment of acute cholangitis: Tokyo Guidelines

|Journal of Hepato-Biliary-Pancreatic Surgery|2007|255